Evidence map›Paper›PMID 27228353›Full record

ArticleCell death & disease2016

Hearts deficient in both Mfn1 and Mfn2 are protected against acute myocardial infarction.

A R Hall, N Burke, R K Dongworth, S B Kalkhoran, A Dyson, J M Vicencio, G W Dorn, D M Yellon, D J Hausenloy

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Cell death & disease, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 131 papers.

0numbers the graph read from it
0cells of the map it votes in
131citing papers in PubMed
7.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

131 citing papers in PubMed, 182 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Targeting mitochondria to protect the heart: a matter of balance?Clinical science (London, England : 1979) · 2025
    Review
  8. Article
  9. Review
  10. Review
  11. Review
  12. Review
  13. Senolysis by GLS1 Inhibition Ameliorates Kidney Aging by Inducing Excessive mPTP Opening Through MFN1.The journals of gerontology. Series A, Biological sciences and medical sciences · 2025
    Article
  14. Review
  15. Review
  16. Review
  17. Review
  18. Article
  19. Review
  20. Review

71 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 3 countries.

A R HallThe Hatter Cardiovascular Institute, University College London, London, UK.
N BurkeThe Hatter Cardiovascular Institute, University College London, London, UK.
R K DongworthThe Hatter Cardiovascular Institute, University College London, London, UK.
S B KalkhoranThe Hatter Cardiovascular Institute, University College London, London, UK.
A DysonDivision of Medicine, University College London, London, UK.
J M VicencioThe Hatter Cardiovascular Institute, University College London, London, UK.
G W DornCenter for Pharmacogenomics, Department of Internal Medicine, Washington University School of Medicine, St Louis, MO, USA.
D M YellonThe Hatter Cardiovascular Institute, University College London, London, UK.
D J HausenloyThe Hatter Cardiovascular Institute, University College London, London, UK.
University College London · GBDuke-NUS Medical School · SGWashington University in St. Louis · US

Funding

MOLECULAR MECHANISM OF APOPTOTIC CARDIOMYOPATHYR01HL059888 · NHLBI · WASHINGTON UNIVERSITY · PI DORN, GERALD W. · 1999 to 2016
$5.4M
MOLECULAR ORCHESTRATION OF MITOCHONDRIAL FITNESS VIA REPLACEMENT OR REPAIRR01HL128441 · NHLBI · WASHINGTON UNIVERSITY · PI DORN, GERALD W. · 2016 to 2016
$381k
British Heart Foundation FS/10/39/28270British Heart Foundation FS/13/41/30368Medical Research Council MR/J003530/1NHLBI NIH HHS R01 HL059888NHLBI NIH HHS R01 HL128441
6 · The paper itself

Abstract

Mitochondria alter their shape by undergoing cycles of fusion and fission. Changes in mitochondrial morphology impact on the cellular response to stress, and their interactions with other organelles such as the sarcoplasmic reticulum (SR). Inhibiting mitochondrial fission can protect the heart against acute ischemia/reperfusion (I/R) injury. However, the role of the mitochondrial fusion proteins, Mfn1 and Mfn2, in the response of the adult heart to acute I/R injury is not clear, and is investigated in this study. To determine the effect of combined Mfn1/Mfn2 ablation on the susceptibility to acute myocardial I/R injury, cardiac-specific ablation of both Mfn1 and Mfn2 (DKO) was initiated in mice aged 4-6 weeks, leading to knockout of both these proteins in 8-10-week-old animals. This resulted in fragmented mitochondria (electron microscopy), decreased mitochondrial respiratory function (respirometry), and impaired myocardial contractile function (echocardiography). In DKO mice subjected to in vivo regional myocardial ischemia (30 min) followed by 24 h reperfusion, myocardial infarct size (IS, expressed as a % of the area-at-risk) was reduced by 46% compared with wild-type (WT) hearts. In addition, mitochondria from DKO animals had decreased MPTP opening susceptibility (assessed by Ca(2+)-induced mitochondrial swelling), compared with WT hearts. Mfn2 is a key mediator of mitochondrial/SR tethering, and accordingly, the loss of Mfn2 in DKO hearts reduced the number of interactions measured between these organelles (quantified by proximal ligation assay), attenuated mitochondrial calcium overload (Rhod2 confocal microscopy), and decreased reactive oxygen species production (DCF confocal microscopy) in response to acute I/R injury. No differences in isolated mitochondrial ROS emissions (Amplex Red) were detected in response to Ca(2+) and Antimycin A, further implicating disruption of mitochondria/SR tethering as the protective mechanism. In summary, despite apparent mitochondrial dysfunction, hearts deficient in both Mfn1 and Mfn2 are protected against acute myocardial infarction due to impaired mitochondria/SR tethering.

Indexed as

AnimalsAntimycin ACalciumGene ExpressionGTP PhosphohydrolasesMiceMice, KnockoutMitochondriaMitochondrial DynamicsMitochondrial Membrane Transport ProteinsMitochondrial Permeability Transition PoreMyocardial InfarctionMyocardial Reperfusion InjuryMyocardiumMyocytes, CardiacReactive Oxygen SpeciesAntimycin ACalciumGTP PhosphohydrolasesMfn1 protein, mouseMfn2 protein, mouseMitochondrial Membrane Transport ProteinsMitochondrial Permeability Transition PoreReactive Oxygen Species

Identifiers

PMID27228353
PMCPMC4917668
OpenAlexW2400538386

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.